Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,730 | 149 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,454 | 95 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $349.17 | 20 | $0 (2024) |
| Medtronic, Inc. | $241.06 | 8 | $0 (2024) |
| Nevro Corp. | $212.29 | 6 | $0 (2023) |
| Boston Scientific Corporation | $180.39 | 2 | $0 (2024) |
| ABBVIE INC. | $86.92 | 5 | $0 (2024) |
| Lundbeck LLC | $71.90 | 4 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $46.56 | 3 | $0 (2024) |
| PFIZER INC. | $39.11 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $19.53 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $752.31 | 29 | Abbott Laboratories ($281.94) |
| 2023 | $156.14 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($55.22) |
| 2022 | $1,211 | 47 | Abbott Laboratories ($1,005) |
| 2021 | $1,611 | 64 | Abbott Laboratories ($1,167) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $147.67 | General |
| Category: Neuromodulation | ||||||
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: Neuromodulation | ||||||
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: Neuromodulation | ||||||
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Neuromodulation | ||||||
| 11/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $73.41 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Neuromodulation | ||||||
| 11/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Neuromodulation | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/21/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $43.78 | General |
| Category: Drug Infusion Systems | ||||||
| 10/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $40.73 | General |
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Neuromodulation | ||||||
| 09/07/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Drug Infusion Systems | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.81 | General |
| Category: Opioid Analgesic | ||||||
| 07/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Gastroenterology | ||||||
| 07/10/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Neuromodulation | ||||||
| 07/10/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Neuromodulation | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Gastroenterology | ||||||
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Gastroenterology | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 598 | 1,735 | $854,093 | $95,825 |
| 2022 | 12 | 626 | 2,175 | $1.1M | $117,670 |
| 2021 | 14 | 805 | 2,384 | $1.5M | $143,345 |
| 2020 | 14 | 824 | 2,083 | $1.3M | $110,218 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 680 | $249,523 | $54,760 | 21.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 33 | 105 | $165,600 | $9,009 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 183 | $60,390 | $8,460 | 14.0% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 20 | 80 | $37,140 | $5,214 | 14.0% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 20 | 85 | $170,000 | $4,635 | 2.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 148 | 369 | $73,800 | $4,464 | 6.0% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 28 | 32 | $45,900 | $3,588 | 7.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 28 | 97 | $38,800 | $3,286 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,576 | $1,320 | 20.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 20 | $5,500 | $671.22 | 12.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 32 | 72 | $864.00 | $417.11 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 957 | $351,219 | $68,276 | 19.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 34 | 130 | $187,200 | $9,689 | 5.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 48 | 63 | $94,500 | $7,128 | 7.5% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2022 | 13 | 112 | $78,400 | $6,722 | 8.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 23 | 82 | $36,778 | $5,730 | 15.6% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2022 | 25 | 92 | $184,000 | $5,182 | 2.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 156 | 393 | $78,600 | $4,755 | 6.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 36 | 117 | $46,800 | $4,148 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 77 | $25,620 | $4,036 | 15.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 17 | $5,100 | $902.03 | 17.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 38 | 119 | $1,428 | $585.93 | 41.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 16 | $4,400 | $515.35 | 11.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 192 | 868 | $434,000 | $69,847 | 16.1% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 45 | 213 | $268,800 | $15,051 | 5.6% |
About Christopher Watson, PA
Christopher Watson, PA is a Medical healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134374424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Watson, PA has received a total of $3,730 in payments from pharmaceutical and medical device companies, with $752.31 received in 2024. These payments were reported across 149 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,730).
As a Medicare-enrolled provider, Watson has provided services to 2,853 Medicare beneficiaries, totaling 8,377 services with total Medicare billing of $467,058. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location San Antonio, TX
- Active Since 12/01/2008
- Last Updated 05/01/2025
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1134374424
Products in Payments
- Proclaim IPG (Device) $1,060
- PROCLAIM (Device) $801.76
- RELISTOR (Drug) $349.17
- Omnia (Device) $192.73
- OCTRODE (Device) $170.11
- Proclaim Plus SCS with FlexBurst360 (Device) $168.70
- General - Pain Management (Device) $139.66
- EON C (Device) $87.29
- INTELLIS ADAPTIVESTIM (Device) $85.09
- VYEPTI (Biological) $71.90
- UBRELVY (Drug) $71.06
- VANTA ADAPTIVESTIM (Device) $68.48
- SYNCHROMEDII (Device) $64.32
- Prodigy Family of SCS IPGs (Device) $61.85
- Belbuca (Drug) $46.56
- Octrode SCS Leads (Device) $31.96
- ENSITE PRECISION (Device) $24.28
- Vanta (Device) $23.17
- PRODIGY (Device) $21.91
- Senza (Device) $19.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in San Antonio
Courtney Aldridge, Pa-C, PA-C
Medical — Payments: $69,797
Shakira Cabrera, Mpas, MPAS
Medical — Payments: $56,253
John Kodosky, Pa-C, PA-C
Medical — Payments: $48,905
Felipe Galvan, Pa, PA
Medical — Payments: $19,150
Amanda Miller, Mph, Mpas, Pa-C, MPH, MPAS, PA-C
Medical — Payments: $15,461
Mrs. Ledyenska Ballesteros, Pa, PA
Medical — Payments: $13,544